指南与共识真菌感染

曲霉PCR技术推荐与侵袭性真菌病定义纳入依据

Aspergillus Polymerase Chain Reaction-An Update on Technical Recommendations, Clinical Applications, and Justification for Inclusion in the Second Revision of the EORTC/MSGERC Definitions of Invasive Fungal Disease.
指南 / 共识 · Clin Infect Dis · 2021-01-01

该文支持将血液和呼吸道样本的曲霉PCR检测纳入EORTC/MSGERC侵袭性真菌病分类定义第二版修订,依据包括方法学标准化、商品化试剂与外部质控可及性及额外临床验证。文章从临床与技术角度提供纳入理由,并总结侵袭性曲霉病分子诊断的近期进展与未来方向。

要点

  • 血液和呼吸道样本曲霉PCR已纳入EORTC/MSGERC侵袭性真菌病定义第二版修订。
  • 纳入依据为方法学标准化、商品化试剂与外部质控及额外临床验证。
  • 文章总结侵袭性曲霉病分子诊断的近期进展与未来发展方向。

核心结论

  • 血液和呼吸道样本的曲霉PCR检测已纳入EORTC/MSGERC侵袭性真菌病分类定义第二版修订。

研究设计与样本

  • 支持性文章,从临床与技术角度阐述曲霉PCR纳入EORTC/MSGERC定义第二版修订的理由。

主要发现

  • 方法学标准化、商品化检测试剂与外部质控项目的可及性以及额外临床验证支持了曲霉PCR的纳入。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Aspergillus polymerase chain reaction testing of blood and respiratory samples has recently been included in the second revision of the EORTC/MSGERC definitions for classifying invasive fungal disease. This is a result of considerable efforts to standardize methodology, the availability of commercial assays and external quality control programs, and additional clinical validation. This supporting article provides both clinical and technical justifications for its inclusion while also summarizing recent advances and likely future developments in the molecular diagnosis of invasive aspergillosis.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. White PL, Bretagne S, Caliendo AM, et al. Aspergillus Polymerase Chain Reaction-An Update on Technical Recommendations, Clinical Applications, and Justification for Inclusion in the Second Revision of the EORTC/MSGERC Definitions of Invasive Fungal Disease. Clin Infect Dis. 2021. PMID: 33709129. doi:10.1093/cid/ciaa1865

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。